Market Research Industry Reports

Tiziana Life Sciences Plc (TILS) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical stage biotechnology company that discovers and develops drugs to treat diseases in oncology and immunology. The companys lead product candidate, TZLS-201, intended for the treatment of thymic carcinoma. Its other clinical programmes include TZLS-401, a human engineered anti-human CD3 antibody intended for the treatment of autoimmune and inflammatory diseases. The companys preclinical stage candidates include TZLS-501, a fully human anti-IL-6R monoclonal antibody targeting the interleukin-6 receptor; and StemPrintER, a multi-gene signature assay intended for the treatment of patients with breast cancer. Tiziana is headquartered in London, the UK.

Tiziana Life Sciences Plc (TILS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Tiziana Life Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 10
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Tiziana Life Sciences Acquires Bio-Repository from Shardna for USD0.3 Million 12
Licensing Agreements 13
Tiziana Life Sciences Enters into Licensing Agreement with Brigham and Womens Hospital 13
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune 14
Tiziana Life Sciences Enters into Licensing Agreement with Nerviano Medical Sciences for Milciclib 15
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune for Foralumab 16
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 17
Equity Offering 18
Tiziana Life Sciences Raises USD0.8 Million in Private Placement of Shares 18
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares 19
Tiziana Life Sciences Raises USD0.2 Million in Private Placement of Shares and Warrants 20
Tiziana Life Sciences Raises USD0.3 Million in Private Placement of Shares 21
Tiziana Life Sciences Raises USD0.4 Million in Private Placement of Shares 22
Tiziana Life Sciences Raises USD0.2 Million in Private Placement of Shares 23
Tiziana Life Sciences Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 24
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 25
Tiziana Life Sciences Raises USD0.3 Million in Private Placement of Shares upon Exercise of Warrants 26
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 27
Tiziana Life Sciences Raises USD3.8 Million in Private Placement of Shares 28
Tiziana Life Sciences Completes Placement for USD3.3 Million 29
Acquisition 30
Alexander David Investments Completes Acquisition of Tiziana Pharma in Reverse Takeover Transaction 30
Tiziana Life Sciences Plc - Key Competitors 31
Tiziana Life Sciences Plc - Key Employees 32
Tiziana Life Sciences Plc - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Jun 07, 2018: Tiziana Life Sciences: Financial Results for the Year Ended 31 December 2017 34
Sep 29, 2017: Tiziana Life Sciences: Interim Results for the Six Months Ended 30 June 2017 41
May 23, 2017: Tiziana Life Sciences: Financial Results for the Year Ended 31 December 2016 47
Corporate Communications 48
Jun 12, 2017: Tiziana Life Sciences Strengthens Unique Research Focus by Appointing Dr Kunwar Shailubhai as Chief Executive Officer 48
Mar 14, 2017: Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board 50
Product News 51
07/28/2017: Publication of Research Article on Foralumab, a Fully Human Anti-CD3 Antibody Being Developed as an Oral Therapy for NASH and Autoimmune Diseases 51
03/14/2017: Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board 52
Clinical Trials 53
Dec 08, 2017: Tiziana Life Sciences Announces Safety of Milciclib in a Phase 2a Trial in Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Patients 53
Nov 23, 2017: Tiziana Life Sciences Announces that Milciclib Met its Primary Endpoint in Two Phase II Clinical Trials in Patients with Thymic Carcinoma and Thymoma 54
Sep 06, 2017: Development of a Proprietary Oral Formulation of Foralumab, a Fully Human Anti-CD3 mAb, for use in an Upcoming Phase 2a Clinical Trial in NASH 56
Jul 19, 2017: Tiziana Life Sciences Announces Initiation of a Phase IIa Clinical Trial with Milciclib in Patients with Hepatocellular Carcinoma 57
Apr 24, 2017: Tiziana Life Sciences Announces Approval of a Phase II Clinical Trial Protocol for Milciclib in Patients with Hepatocellular Carcinoma 58
Apr 21, 2017: Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib in Patients with Refractory Solid Tumours 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List Of Tables

List of Tables
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tiziana Life Sciences Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Tiziana Life Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 10
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Tiziana Life Sciences Acquires Bio-Repository from Shardna for USD0.3 Million 12
Tiziana Life Sciences Enters into Licensing Agreement with Brigham and Womens Hospital 13
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune 14
Tiziana Life Sciences Enters into Licensing Agreement with Nerviano Medical Sciences for Milciclib 15
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune for Foralumab 16
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 17
Tiziana Life Sciences Raises USD0.8 Million in Private Placement of Shares 18
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares 19
Tiziana Life Sciences Raises USD0.2 Million in Private Placement of Shares and Warrants 20
Tiziana Life Sciences Raises USD0.3 Million in Private Placement of Shares 21
Tiziana Life Sciences Raises USD0.4 Million in Private Placement of Shares 22
Tiziana Life Sciences Raises USD0.2 Million in Private Placement of Shares 23
Tiziana Life Sciences Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 24
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 25
Tiziana Life Sciences Raises USD0.3 Million in Private Placement of Shares upon Exercise of Warrants 26
Tiziana Life Sciences Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 27
Tiziana Life Sciences Raises USD3.8 Million in Private Placement of Shares 28
Tiziana Life Sciences Completes Placement for USD3.3 Million 29
Alexander David Investments Completes Acquisition of Tiziana Pharma in Reverse Takeover Transaction 30
Tiziana Life Sciences Plc, Key Competitors 31
Tiziana Life Sciences Plc, Key Employees 32
Tiziana Life Sciences Plc, Other Locations 33
Tiziana Life Sciences Plc, Subsidiaries 33

List Of Figures

List of Figures
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Tiziana Life Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 10

Tiziana Life Sciences Plc (TILS) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical stage biotechnology company that discovers and develops drugs to treat diseases in oncology and immunology. The companys

USD 250View Report

TIZIANA LIFE SCIENCES PLC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

TIZIANA LIFE SCIENCES PLC Company Profile is a detailed strategic and analytical report on TIZIANA LIFE SCIENCES PLC. The 2018 version of the report offers detailed insights into the companys

USD 200View Report

Noble Life Sciences Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers vaccines, drugs, and medical device development services. The company provides preclinical services such as disease and

USD 250View Report

MDNA Life Sciences Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The companys prostate core mitomic test is based on the science

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jul 2018
No. of Pages :60
Country :United Kingdom
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube